Company: GEHC
Filing Date: 2025-10-29
Form Type: 10-Q
Source: 0001932393-25-000053
Chunk: 51

Company: GE HealthCare Technologies Inc.
Filing Date: 2025-10-29
Form: 10-Q
Item: Item 1
Chunk 51
---
%4%$6,693$6,4624%3%AVS    1,3011,2167%6%3,8293,6924%4%PCS    731779(6)%(7)%2,2622,298(2)%(2)%PDx    74962520%10%2,1101,86213%7%Other(1)     15153339Total revenues    $5,143$4,8636%4%$14,927$14,3534%3%

(1) Financial information not presented within the reportable segments, shown within the Other category, represents HealthCare Financial Services which does not meet the definition of an operating segment.

Revenues by RegionFor the three months ended September 30For the nine months ended September 3020252024% change20252024 % changeUnited States and Canada (“USCAN”)    $2,358$2,2465%$6,934$6,5825%Europe, the Middle East, and Africa (“EMEA”)    1,3601,23710%3,8023,6175%China region    547564(3)%1,7041,745(2)%Rest of World    8798168%2,4872,4083%Total revenues    $5,143$4,8636%$14,927$14,3534%

For the three months ended September 30, 2025

Total revenues were $5,143 million, growing 6% as reported and 4% organically*. Sales of products increased 5% or $174 million primarily driven by strong growth in PDx, Imaging, and AVS revenues. Sales of services increased 6% or $107 million primarily driven by growth in new and existing customer contractual agreements.

____________________

*Non-GAAP Financial Measure

33

The segment revenues were as follows:

•Imaging segment revenues were $2,349 million, growing 5% or $120 million, led by growth in the EMEA and USCAN regions;

•AVS segment revenues were $1,301 million, growing 7% or $84 million, with strength in the U.S. market;

•PCS segment revenues were $731 million, decreasing 6% or $48 million, primarily driven by a product hold; and

•PDx segment revenues were $749 million, growing 20